Manuel Chacón-Diaz
Research Subjects
Manuel Chacón-Diaz has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Ofelia Araoz Tarco
Instituto Nacional Cardiovascular (INCOR), EsSalud. Lima, Perú
7 shared publications - Akram Hernández-Vásquez
Centro de Excelencia en Investigaciones Económicas y Sociales en Salud, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima 15024, Peru
6 shared publications - Piero Custodio-Sánchez
Hospital Nacional Almanzor Aguinaga Asenjo - EsSalud. Unidad de cardiología intervencionista. Chiclayo, Perú. Hospital Nacional Almanzor Aguinaga Asenjo - EsSalud Unidad de cardiología intervencionista Chiclayo Perú
4 shared publications - Ana Cecilia Gonzales-Luna
Instituto Nacional Cardiovascular (INCOR), EsSalud. Lima, Perú
3 shared publications - Anibal Diaz-Lazo
Universidad de Huánuco. Huánuco, Perú
3 shared publications - Carlos Rubén Barrientos
Hospital Nacional del Centro Daniel Alcides Carrión, Huancayo, Perú; Universidad Continental, Huancayo, Perú
3 shared publications
Latest Publications
- Open Access
- 28 March 2026
- Vol. 7 (1) , 52-60
The cardiovascular system and high-altitude exposure: from adaptation to disease. Part I
Exposure to high altitude constitutes a complex physiological challenge, driven primarily by hypobaric hypoxia and, in some settings, by extreme environmental conditions such as severe cold and increased ultraviolet radiation. At the cardiovascular level, this exposure elicits a range of acute and chronic adaptations, including activation of the sympathetic nervous system, pulmonary vasoconstriction, and vascular and ventricular remodelling. In the Andean region, millions of people live at elevations above 2,500 metres above sea level, rendering them particularly susceptible to these physiological adaptations and the associated cardiovascular alterations. This manuscript represents the first part of a narrative review and aims to synthesise the available scientific evidence on mechanisms of adaptation to high altitude, as well as the characteristics of pulmonary hypertension, heart failure, and congenital heart disease observed in both native high-altitude populations and individuals originating from low-altitude areas. In addition, it seeks to identify existing gaps in current knowledge of these conditions in order to promote the development of specific diagnostic, preventive, and therapeutic strategies aimed at improving cardiovascular health among populations residing at or temporarily exposed to high altitude.
- 28 March 2026
- Vol. 7 (1) , 52-60
Open AccessThe cardiovascular system and high-altitude exposure: from adaptation to disease. Part I
Exposure to high altitude constitutes a complex physiological challenge, driven primarily by hypobaric hypoxia and, in some settings, by extreme environmental conditions such as severe cold and increased ultraviolet radiation. At the cardiovascular level, this exposure elicits a range of acute and chronic adaptations, including activation of the sympathetic nervous system, pulmonary vasoconstriction, and vascular and ventricular remodelling. In the Andean region, millions of people live at elevations above 2,500 metres above sea level, rendering them particularly susceptible to these physiological adaptations and the associated cardiovascular alterations. This manuscript represents the first part of a narrative review and aims to synthesise the available scientific evidence on mechanisms of adaptation to high altitude, as well as the characteristics of pulmonary hypertension, heart failure, and congenital heart disease observed in both native high-altitude populations and individuals originating from low-altitude areas. In addition, it seeks to identify existing gaps in current knowledge of these conditions in order to promote the development of specific diagnostic, preventive, and therapeutic strategies aimed at improving cardiovascular health among populations residing at or temporarily exposed to high altitude.
- Open Access
- 12 March 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 1-8
Manejo y percepciones sobre la anemia y deficiencia de hierro previo a cirugía cardíaca
Introducción. La anemia y la deficiencia de hierro (DH) son condiciones frecuentes en pacientes con enfermedades cardiovasculares y se asocian a mayor morbimortalidad en cirugía cardíaca. Sin embargo, no existen datos sobre cómo es abordada esta problemática en Iberoamérica. Debido a ello, desde la Sociedad Interamericana de Cardiología nos propusimos explorar conocimientos, actitudes y conductas de médicos latinoamericanos involucrados en el perioperatorio de cirugía cardíaca. Materiales y métodos. Se realizó un estudio transversal mediante una encuesta electrónica anónima distribuida entre enero y agosto de 2025, utilizando un muestreo tipo «bola de nieve». Se incluyeron médicos con actividad asistencial que involucre la atención de pacientes previa a cirugía cardíaca. Resultados. Respondieron la encuesta 881 médicos de 23 países. Si bien el 83,7% manifestó que tamizaba la presencia de anemia de forma rutinaria, solo el 43,7% expresó evaluar la DH. Un 18,2% manifestó contar con protocolos institucionales sobre este tópico. El manejo terapéutico mostró notables diferencias: solo el 11,8% indicó administrar hierro endovenoso (EV) ante el diagnóstico de anemia o DH. El 46,9% de los participantes expresó tener acceso rutinario a hierro EV; sin embargo, solo el 26,6% de ellos refirió haber indicado esta intervención a pacientes en el preoperatorio de cirugía cardíaca en los 6 meses previos a responder la encuesta. Además, el 54,8% de los encuestados no había recibido formación específica y se sentía solo moderadamente preparado para manejar estas condiciones. Conclusión. Nuestros datos sugieren que existen brechas significativas entre la evidencia disponible y la práctica clínica en el manejo preoperatorio de anemia y DH, destacando la necesidad de protocolos institucionales y mayor educación médica especializada.
- 12 March 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 1-8
Open AccessManejo y percepciones sobre la anemia y deficiencia de hierro previo a cirugía cardíaca
Introducción. La anemia y la deficiencia de hierro (DH) son condiciones frecuentes en pacientes con enfermedades cardiovasculares y se asocian a mayor morbimortalidad en cirugía cardíaca. Sin embargo, no existen datos sobre cómo es abordada esta problemática en Iberoamérica. Debido a ello, desde la Sociedad Interamericana de Cardiología nos propusimos explorar conocimientos, actitudes y conductas de médicos latinoamericanos involucrados en el perioperatorio de cirugía cardíaca. Materiales y métodos. Se realizó un estudio transversal mediante una encuesta electrónica anónima distribuida entre enero y agosto de 2025, utilizando un muestreo tipo «bola de nieve». Se incluyeron médicos con actividad asistencial que involucre la atención de pacientes previa a cirugía cardíaca. Resultados. Respondieron la encuesta 881 médicos de 23 países. Si bien el 83,7% manifestó que tamizaba la presencia de anemia de forma rutinaria, solo el 43,7% expresó evaluar la DH. Un 18,2% manifestó contar con protocolos institucionales sobre este tópico. El manejo terapéutico mostró notables diferencias: solo el 11,8% indicó administrar hierro endovenoso (EV) ante el diagnóstico de anemia o DH. El 46,9% de los participantes expresó tener acceso rutinario a hierro EV; sin embargo, solo el 26,6% de ellos refirió haber indicado esta intervención a pacientes en el preoperatorio de cirugía cardíaca en los 6 meses previos a responder la encuesta. Además, el 54,8% de los encuestados no había recibido formación específica y se sentía solo moderadamente preparado para manejar estas condiciones. Conclusión. Nuestros datos sugieren que existen brechas significativas entre la evidencia disponible y la práctica clínica en el manejo preoperatorio de anemia y DH, destacando la necesidad de protocolos institucionales y mayor educación médica especializada.
- Open Access
- 2 February 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 61-69
El sistema cardiovascular y la exposición a gran altitud: desde la adaptación a la enfermedad. Parte II
En esta segunda parte de la revisión narrativa sobre la patología cardiovascular en gran altitud, se abordan las características clínicas y fisiopatológicas de la enfermedad coronaria aguda y crónica, las arritmias cardíacas y la hipertensión arterial en condiciones de hipoxia hipobárica. Finalmente, se destacan los principales vacíos en el conocimiento actual y las oportunidades para el desarrollo de investigaciones orientadas a comprender mejor estas enfermedades en las poblaciones que habitan permanentemente a gran altitud.
- 2 February 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 61-69
Open AccessEl sistema cardiovascular y la exposición a gran altitud: desde la adaptación a la enfermedad. Parte II
En esta segunda parte de la revisión narrativa sobre la patología cardiovascular en gran altitud, se abordan las características clínicas y fisiopatológicas de la enfermedad coronaria aguda y crónica, las arritmias cardíacas y la hipertensión arterial en condiciones de hipoxia hipobárica. Finalmente, se destacan los principales vacíos en el conocimiento actual y las oportunidades para el desarrollo de investigaciones orientadas a comprender mejor estas enfermedades en las poblaciones que habitan permanentemente a gran altitud.
- Open Access
- 2 February 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 52-60
El sistema cardiovascular y la exposición a gran altitud: desde la adaptación a la enfermedad. Parte I
Exposure to high altitude constitutes a complex physiological challenge, driven primarily by hypobaric hypoxia and, in some settings, by extreme environmental conditions such as severe cold and increased ultraviolet radiation. At the cardiovascular level, this exposure elicits a range of acute and chronic adaptations, including activation of the sympathetic nervous system, pulmonary vasoconstriction, and vascular and ventricular remodelling. In the Andean region, millions of people live at elevations above 2,500 metres above sea level, rendering them particularly susceptible to these physiological adaptations and the associated cardiovascular alterations. This manuscript represents the first part of a narrative review and aims to synthesise the available scientific evidence on mechanisms of adaptation to high altitude, as well as the characteristics of pulmonary hypertension, heart failure, and congenital heart disease observed in both native high-altitude populations and individuals originating from low-altitude areas. In addition, it seeks to identify existing gaps in current knowledge of these conditions in order to promote the development of specific diagnostic, preventive, and therapeutic strategies aimed at improving cardiovascular health among populations residing at or temporarily exposed to high altitude.
- 2 February 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 52-60
Open AccessEl sistema cardiovascular y la exposición a gran altitud: desde la adaptación a la enfermedad. Parte I
Exposure to high altitude constitutes a complex physiological challenge, driven primarily by hypobaric hypoxia and, in some settings, by extreme environmental conditions such as severe cold and increased ultraviolet radiation. At the cardiovascular level, this exposure elicits a range of acute and chronic adaptations, including activation of the sympathetic nervous system, pulmonary vasoconstriction, and vascular and ventricular remodelling. In the Andean region, millions of people live at elevations above 2,500 metres above sea level, rendering them particularly susceptible to these physiological adaptations and the associated cardiovascular alterations. This manuscript represents the first part of a narrative review and aims to synthesise the available scientific evidence on mechanisms of adaptation to high altitude, as well as the characteristics of pulmonary hypertension, heart failure, and congenital heart disease observed in both native high-altitude populations and individuals originating from low-altitude areas. In addition, it seeks to identify existing gaps in current knowledge of these conditions in order to promote the development of specific diagnostic, preventive, and therapeutic strategies aimed at improving cardiovascular health among populations residing at or temporarily exposed to high altitude.
- Open Access
- 25 November 2024
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 5 (4) , 187-197
Tendencias en la epidemiología del infarto agudo de miocardio en el Perú: un análisis de los registros oficiales de SUSALUD
Objetivo. Determinar la tasa de eventos de infarto agudo de miocardio (IAM) estandarizada por edad y su tendencia en los últimos años. Materiales y métodos. Se realizó un estudio ecológico de datos secundarios sobre la morbilidad en áreas de emergencia de hospitales peruanos entre 2018 y 2023. Se identificaron casos de IAM en adultos de 20 años o más mediante los códigos CIE-10. Se calcularon las tasas de eventos de IAM por 100 000 personas, estandarizadas por edad. Además, se calculó el cambio de la tasa de eventos entre los años extremos, y se utilizó una regresión de Poisson para estimar el cambio porcentual anual de las tasas de eventos junto a su intervalo de confianza (IC) al 95%, ajustando por edad y año calendario. Estas tasas se estratificaron por sexo y región político-administrativa. Resultados. Se registraron 28 088 eventos de IAM entre 2018 y 2023. La tasa nacional estandarizada por edad aumentó de 22,77 en 2018 a 25,60 por 100 000 personas en 2023, con un cambio porcentual anual de 6,72% (IC 95%: 4,25-9,25). Los hombres presentaron tasas de eventos de IAM más altas comparado con las mujeres en todo el periodo de estudio. Además, las tasas de eventos más altas se observaron en la Provincia Constitucional del Callao, San Martín y Loreto. Conclusiones. Nuestros hallazgos proporcionan un mejor conocimiento de la epidemiología del IAM en el Perú y su evolución en los últimos años, datos importantes para mejorar las estrategias de prevención, tratamiento y distribución de recursos para el manejo del IAM.
- 25 November 2024
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 5 (4) , 187-197
Open AccessTendencias en la epidemiología del infarto agudo de miocardio en el Perú: un análisis de los registros oficiales de SUSALUD
Objetivo. Determinar la tasa de eventos de infarto agudo de miocardio (IAM) estandarizada por edad y su tendencia en los últimos años. Materiales y métodos. Se realizó un estudio ecológico de datos secundarios sobre la morbilidad en áreas de emergencia de hospitales peruanos entre 2018 y 2023. Se identificaron casos de IAM en adultos de 20 años o más mediante los códigos CIE-10. Se calcularon las tasas de eventos de IAM por 100 000 personas, estandarizadas por edad. Además, se calculó el cambio de la tasa de eventos entre los años extremos, y se utilizó una regresión de Poisson para estimar el cambio porcentual anual de las tasas de eventos junto a su intervalo de confianza (IC) al 95%, ajustando por edad y año calendario. Estas tasas se estratificaron por sexo y región político-administrativa. Resultados. Se registraron 28 088 eventos de IAM entre 2018 y 2023. La tasa nacional estandarizada por edad aumentó de 22,77 en 2018 a 25,60 por 100 000 personas en 2023, con un cambio porcentual anual de 6,72% (IC 95%: 4,25-9,25). Los hombres presentaron tasas de eventos de IAM más altas comparado con las mujeres en todo el periodo de estudio. Además, las tasas de eventos más altas se observaron en la Provincia Constitucional del Callao, San Martín y Loreto. Conclusiones. Nuestros hallazgos proporcionan un mejor conocimiento de la epidemiología del IAM en el Perú y su evolución en los últimos años, datos importantes para mejorar las estrategias de prevención, tratamiento y distribución de recursos para el manejo del IAM.
- Open Access
- 1 October 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1414519
Case Report: Spontaneous acute hemopericardium
Acute hemopericardium is generally produced by complications of interventional procedures or traumatisms to the chest wall. In absence of those antecedents, clinicians face an arduous process of etiological diagnosis and treatment. We present the case of a male patient with history of Hodgkin's lymphoma and aortic endovascular treatment years ago, who develop an episode of fever, chest pain and dyspnea that was complicated with cardiac tamponade diagnosed with echocardiogram and angio- tomography. In the operating room hemopericardium was diagnosed and drained with resolution of symptoms. Diagnosis work out was carried out with suspicion of tuberculous or neoplastic pericarditis with negative results. Patient was discharged with the diagnoses of viral or idiopathic pericarditis. The case highlights the use of multimodality images and laboratories procedures to lead to a correct diagnoses and treatment.
- 1 October 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1414519
Open AccessCase Report: Spontaneous acute hemopericardium
Acute hemopericardium is generally produced by complications of interventional procedures or traumatisms to the chest wall. In absence of those antecedents, clinicians face an arduous process of etiological diagnosis and treatment. We present the case of a male patient with history of Hodgkin's lymphoma and aortic endovascular treatment years ago, who develop an episode of fever, chest pain and dyspnea that was complicated with cardiac tamponade diagnosed with echocardiogram and angio- tomography. In the operating room hemopericardium was diagnosed and drained with resolution of symptoms. Diagnosis work out was carried out with suspicion of tuberculous or neoplastic pericarditis with negative results. Patient was discharged with the diagnoses of viral or idiopathic pericarditis. The case highlights the use of multimodality images and laboratories procedures to lead to a correct diagnoses and treatment.
- Open Access
- 21 December 2023
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 4 (4) , 164-183
Propuesta de manejo inicial del infarto de miocardio con elevación del segmento ST no complicado en centros sin capacidad de intervención coronaria percutánea en el Perú
ST-segment elevation myocardial infarction (STEMI) is a clinical entity whose adequate treatment will depend on its prompt recognition, accurate diagnosis, and management in reperfusion networks. The first contact with these patients is generally done in centers without reperfusion capacity, attended by non-cardiologist doctors, and in centers far from hospitals with greater resolution capacity, something that is well known in our country. This manuscript proposes a strategy for the diagnosis and treatment of STEMI in centers without percutaneous coronary intervention capacity of the public health system in Peru, emphasizing not losing sight of electrocardiographic patterns compatible with coronary artery occlusion, adequate fibrinolysis and management of its complications, the treatment of infarction in special populations and highlighting the importance of the pharmacoinvasive strategy as the main form of reperfusion treatment in our country.
- 21 December 2023
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 4 (4) , 164-183
Open AccessPropuesta de manejo inicial del infarto de miocardio con elevación del segmento ST no complicado en centros sin capacidad de intervención coronaria percutánea en el Perú
ST-segment elevation myocardial infarction (STEMI) is a clinical entity whose adequate treatment will depend on its prompt recognition, accurate diagnosis, and management in reperfusion networks. The first contact with these patients is generally done in centers without reperfusion capacity, attended by non-cardiologist doctors, and in centers far from hospitals with greater resolution capacity, something that is well known in our country. This manuscript proposes a strategy for the diagnosis and treatment of STEMI in centers without percutaneous coronary intervention capacity of the public health system in Peru, emphasizing not losing sight of electrocardiographic patterns compatible with coronary artery occlusion, adequate fibrinolysis and management of its complications, the treatment of infarction in special populations and highlighting the importance of the pharmacoinvasive strategy as the main form of reperfusion treatment in our country.
- Open Access
- 13 December 2023
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 4 (4) , 151-156
Chronic exposure to high altitude and the presence of coronary ectasia in patients with ST elevation myocardial infarction
Objective. To evaluate the association between chronic exposure to high altitude and the presence of coronary ectasia (CE) in patients with ST-segment elevation myocardial infarction (STEMI) treated in a highly specialized cardiovascular reference hospital in Peru. Materials and methods. Retrospective matched case-control study. The cases were patients with CE and controls without CE. The relationship between CE and chronic exposure to high altitude was evaluated considering intervening variables such as arterial hypertension, diabetes mellitus, dyslipidemia, smoking, and hematocrit values. Patients with chronic inflammatory pathologies, chronic obstructive pulmonary disease, and previous revascularization were excluded. Multivariate logistic regression was applied to obtain the OR value and their respective confidence intervals. Results. Eighteen cases and 18 controls were studied, most of them were men with an average age of 65 years. Thirty-six percent of the population came from high altitude; in this group 76.9% had coronary ectasia of the infarct-related artery. The mean hematocrit value was slightly higher in the high-altitude native (46 ± 7% versus 42 ± 5%, p=0.094). Multivariate conditional logistic regression did not find a significant relationship between exposure to high altitude and the risk of presenting CE (OR:6.03, IC95%: 0.30-118, p=0.236). Conclusions. In patients with STEMI, we found no association between chronic exposure to high altitude and coronary ectasia.
- 13 December 2023
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 4 (4) , 151-156
Open AccessChronic exposure to high altitude and the presence of coronary ectasia in patients with ST elevation myocardial infarction
Objective. To evaluate the association between chronic exposure to high altitude and the presence of coronary ectasia (CE) in patients with ST-segment elevation myocardial infarction (STEMI) treated in a highly specialized cardiovascular reference hospital in Peru. Materials and methods. Retrospective matched case-control study. The cases were patients with CE and controls without CE. The relationship between CE and chronic exposure to high altitude was evaluated considering intervening variables such as arterial hypertension, diabetes mellitus, dyslipidemia, smoking, and hematocrit values. Patients with chronic inflammatory pathologies, chronic obstructive pulmonary disease, and previous revascularization were excluded. Multivariate logistic regression was applied to obtain the OR value and their respective confidence intervals. Results. Eighteen cases and 18 controls were studied, most of them were men with an average age of 65 years. Thirty-six percent of the population came from high altitude; in this group 76.9% had coronary ectasia of the infarct-related artery. The mean hematocrit value was slightly higher in the high-altitude native (46 ± 7% versus 42 ± 5%, p=0.094). Multivariate conditional logistic regression did not find a significant relationship between exposure to high altitude and the risk of presenting CE (OR:6.03, IC95%: 0.30-118, p=0.236). Conclusions. In patients with STEMI, we found no association between chronic exposure to high altitude and coronary ectasia.
- Open Access
- 30 December 2022
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 3 (4) , 196-203
Clinical variables associated with no-reflow after percutaneous coronary intervention in ST-segment elevation myocardial infarction: Secondary analysis of the PERSTEMI I and II study
Objective. To determine the clinical factors associated to no-reflow after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) in Peru. Materials and methods. Case - control retrospective study, derived from the PERSTEMI (Peruvian Registry of ST-elevation myocardial infarction) I and II study. Cases (group 1) were those patients who presented no-reflow after PCI, defined by a TIMI flow < 3, and controls (group 2) were those with a TIMI 3 flow after the intervention. Clinical and angiographic variables were compared between both groups, and a multivariate analysis was performed looking for associated factors to no-reflow. Results. We included 75 cases and 304 controls. The incidence of no-reflow was 19.8%. There was a higher frequency of no-reflow in patients with primary PCI compared to the pharmacoinvasive strategy, in patients with one-vessel disease and in those with TIMI 0 before PCI. In-hospital mortality and heart failure were higher in patients with no-reflow (21.3% vs. 2.9% and 45.3% vs. 16.5, respectively; p 12 hours, Killip Kimball (KK) > I, TIMI 0 before PCI, and one-vessel disease were the factors significantly associated with no-reflow after PCI. Conclusions. The ischemia time greater than 12 hours, the highest KK score, the presence of an occluded culprit artery (TIMI 0) before PCI and an one-vessel disease, were factors independently associated to no-reflow in patients with STEMI in Peru.
- 30 December 2022
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 3 (4) , 196-203
Open AccessClinical variables associated with no-reflow after percutaneous coronary intervention in ST-segment elevation myocardial infarction: Secondary analysis of the PERSTEMI I and II study
Objective. To determine the clinical factors associated to no-reflow after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) in Peru. Materials and methods. Case - control retrospective study, derived from the PERSTEMI (Peruvian Registry of ST-elevation myocardial infarction) I and II study. Cases (group 1) were those patients who presented no-reflow after PCI, defined by a TIMI flow < 3, and controls (group 2) were those with a TIMI 3 flow after the intervention. Clinical and angiographic variables were compared between both groups, and a multivariate analysis was performed looking for associated factors to no-reflow. Results. We included 75 cases and 304 controls. The incidence of no-reflow was 19.8%. There was a higher frequency of no-reflow in patients with primary PCI compared to the pharmacoinvasive strategy, in patients with one-vessel disease and in those with TIMI 0 before PCI. In-hospital mortality and heart failure were higher in patients with no-reflow (21.3% vs. 2.9% and 45.3% vs. 16.5, respectively; p 12 hours, Killip Kimball (KK) > I, TIMI 0 before PCI, and one-vessel disease were the factors significantly associated with no-reflow after PCI. Conclusions. The ischemia time greater than 12 hours, the highest KK score, the presence of an occluded culprit artery (TIMI 0) before PCI and an one-vessel disease, were factors independently associated to no-reflow in patients with STEMI in Peru.